A drug to treat stroke showed efficacy in treating middle-ear infections by suppressing mucus overproduction, improving bacterial clearance, and reducing hearing loss, researchers from the Georgia State University and University of Rochester reported.
Clinically superior, cost less than oral antibiotics, observation for children with tympanostomy tubes
Longer therapy with oral valganciclovir may modestly improve long-term developmental outcomes and hearing in neonates with symptomatic congenital cytomegalovirus (CMV) disease, reports a study in the New England Journal of Medicine.
Featured courses from mycme
This module reviews all topics on the NCCPA examination blueprint relating to Pulmonology, Ophthalmology, and ...
Preventing versus managing pediatric allergies can improve a child’s physical and mental health, enhance quality ...
An understanding of the growing problem of allergic disease, how AD is the entryway into ...
- McDonald's and the Microbiome: What Effect Does Junk Food Have on Gut Bacteria?
- When the Doctor is Depressed: One Clinician Tells His Story
- Spice + Statin Likely Culprit in Patient with Acute Hepatitis
- Most Distinctive Causes of Death Mapped by U.S. State
- First Non-Surgical Tx for "Double Chin" Gains FDA Approval
- Heart Rate May Be an Indicator of Future Diabetes Risk
- Probiotic Mixture VSL#3 Shows Promise for Crohn's Recurrence
- Study: Beloranib Appears Safe, Efficacious for Weight Loss in Obesity
- Progress Toward Mind-Controlled Robotic Limbs
- Response to Resistance Exercise Depends on a Person's Genetic Risk for Obesity